Q. Zhao

Mixed backbone oligonucleotides: improvement in oligonucleotide-induced toxicity in vivo.

S. Agrawal, Qiuyan Zhao, Q. Zhao, 1998, Antisense & nucleic acid drug development.

Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy.

Qiuyan Zhao, A. Krieg, S. Matson, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies.

S. Agrawal, R. Zhang, C. Saxinger, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Effect of different chemically modified oligodeoxynucleotides on immune stimulation.

S. Agrawal, Qiuyan Zhao, Zhiwei Jiang, 1996, Biochemical Pharmacology.

Accessible 5'-end of CpG-containing phosphorothioate oligodeoxynucleotides is essential for immunostimulatory activity.

S. Agrawal, E. Kandimalla, Q. Zhao, 2000, Bioorganic & medicinal chemistry letters.

Conjugate chemistry and cellular processing of EGF-dextran.

H. Lundqvist, E. Blomquist, J. Carlsson, 1999, Acta oncologica.

Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery.

S. Agrawal, Qiuyan Zhao, J. Temsamani, 1995, Antisense research and development.

Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice.

S. Agrawal, Qiuyan Zhao, J. Temsamani, 1998, Antisense & nucleic acid drug development.